The board of directors of Sanai Health Industry Group Company Limited announced that Mr. Cheng Hok Kai, Frederick has been appointed as an executive director of the Company with effect from 9 May 2019. Mr. Cheng will be primarily responsible for the cannabidiol business and genetic testing business of the Company and its subsidiaries. Mr. Cheng, aged 55, has extensive experience in business, finance and accounting management. From April 2010 to January 2018, Mr. Cheng worked in PuraPharm Corporation Limited. Throughout the period, Mr. Cheng had served in various positions including chief financial officer, company secretary, and managing director of corporate finance and investment.